ArticleMedicine2025
Clinical and genetic analysis of a female child with duplications at 7p22.3p22.1 and Xp22.31p21.1: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleIntellectual disability (ID) is a neurodevelopmental disorder with diverse etiologies. Chromosomal duplications are recognized as a common cause of ID, with manifestations typically milder than those associated with deletions. Duplications involving the short arm of chromosome 7 or the X chromosome have been linked to ID. Limited data exist on duplications at 7p22.1p22.3 and Xp22.31p21.1, leaving their clinical significance largely unexplored. This case report aims to expand the phenotype and genetics spectrum of 7p22 duplication syndrome and X-linked ID. Special attention should be paid to closely monitoring the pubertal progression of such patients. PATIENT CONCERNS: A 9-year-10-month-old female was admitted to our hospital due to distinctive dysmorphic features and ID. DIAGNOSES: Upon examination, features of craniofacial dysmorphism were observed, including micrognathia, a prominent lower lip, a thin upper lip, a flat nasal bridge, and hypertelorism. The child's pubertal development is progressing extremely rapidly; at under 10 years old, the breasts have already advanced to Tanner Stage 4. Her height was within the median range, but her bone age was advanced (12.1 years). Her full-scale intelligence quotient, assessed using the Wechsler Intelligence Scale for Children: 4th edition, was 41.
interventionsWhole exome sequencing identified a de novo duplication spanning overlapping regions at Xp21-22 and 7p22. This duplication encompasses several genes implicated in ID, including Duchenne muscular dystrophy, Aristaless-related homeobox, interleukin-1 receptor accessory protein like 1, adaptor-related protein complex 1 subunit sigma 2, and cyclin-dependent kinase-like 5. OUTCOMES: A novel duplication in the Xp and 7p of a Chinese female child diagnosed with ID and dysmorphic features has been studied by whole exome sequencing analysis. The novel duplications were a large duplication located in the 7p22.1 to p22.3 region, spanning 12.07 Mb, and a large duplication located in the Xp22.31 to p21.1 region, spanning 24.7 Mb. LESSONS: Our study underscores the importance of comprehensive clinical and genetic evaluation in individuals with duplication on the X chromosome and the terminal region of chromosome 7's short arm. We highlight the need for monitoring these patients for growth and sexual development issues. Our findings also suggest that chromosomal duplication can lead to severe clinical manifestations, emphasizing the critical role of genetic assessment in managing such cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.